12.06 0.00 (0.00%)
After hours: 4:39PM EDT
|Bid||12.07 x 1400|
|Ask||16.00 x 800|
|Day's Range||12.00 - 12.54|
|52 Week Range||9.97 - 16.54|
|Beta (3Y Monthly)||0.72|
|PE Ratio (TTM)||18.27|
|Earnings Date||May 7, 2019 - May 13, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||17.83|
LOS ANGELES, March 25, 2019 -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of.
RadNet Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, and among others. RadNet Inc had annual average EBITDA growth of 2.20% over the past ten years.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Lawyers in Overland Park helped their client, RadNet Inc., win the verdict against Topeka-based physician group Radiology and Nuclear Medicine LLC.
RadNet (RDNT) delivered earnings and revenue surprises of 210.53% and 2.59%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Los Angeles-based company said it had profit of 59 cents. The operator of medical diagnostic imaging centers posted revenue of $257.2 million in the period. For the year, the ...
For the fourth quarter of 2018, RadNet reports Total Net Revenue (“Revenue”) of $257.2 million and Adjusted EBITDA()of $46.2 million; Adjusted EBITDA(1) includes adjustments.
LOS ANGELES, March 05, 2019 -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned.
LOS ANGELES, March 04, 2019 -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services,.
NEW YORK, Feb. 26, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
RadNet, Inc. (RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported it has signed a definitive agreement to acquire the outpatient radiology practice of Kern Radiology Medical Group, Inc. (“Kern Radiology”), the owner of five imaging centers in Bakersfield, California. The transaction is expected to close in April. For more than 50 years, Kern Radiology has serviced the communities of Bakersfield and Kern County, California, comprising over 380,000 and 800,000 people, respectively. Its imaging centers, which employ approximately 200 team members, provide multimodality offerings including MRI, CT, PET/CT, X-ray, Ultrasound, Bone Density, Nuclear Medicine and Interventional procedures. In addition, Kern Radiology provides radiology services to Bakersfield Memorial Hospital, Mercy Southwest Hospital and Mercy Downtown Hospital.
RadNet, Inc. (RDNT) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile […]
30 imaging centers within short distances of MemorialCare physician offices in Orange & Los Angeles counties ORANGE and LOS ANGELES Counties, Calif., Dec. 13, 2018 /PRNewswire/ -- MemorialCare , nationally ...
The Cancer Research Collaboration (CRC), a non-profit organization dedicated to expanding the availability of cutting-edge cancer research, in partnership with RadNet, Inc. (RDNT), a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, are, once again, proud to work in conjunction with Blue Mesa Health’s (“Blue Mesa”) Transform diabetes prevention program. Since 2016, Blue Mesa’s CDC-recognized diabetes prevention programs Transform and Transformemos have been helping stem the tide of rising chronic disease-related health costs — a situation where approximately one-third of Americans is prediabetic. The programs are based on the Centers for Disease Control and Prevention’s (CDC) landmark National Diabetes Prevention Program.
NEW YORK, Nov. 27, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Insurers and patients are increasingly embracing low-cost, on-demand healthcare solutions from companies like Teladoc.
RadNet (RDNT) delivered earnings and revenue surprises of -33.33% and -0.06%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
The Los Angeles-based company said it had profit of 10 cents per share. The operator of medical diagnostic imaging centers posted revenue of $242.1 million in the period. RadNet expects full-year revenue ...
Total Net Revenue (“Revenue”) increased 6.4% to $242.1 million in the third quarter of 2018 from $227.6 million in the third quarter of 2017Adjusted EBITDA(1) increased 5.5% to.
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.